Menu UF Health Home Menu
 

Faculty & Staff

Program Faculty and Affiliates


Kimberly A. Burns, R.Ph., J.D.

Kimberly A. Burns

Dr. Burns is a licensed pharmacist and attorney in Pennsylvania. In addition to her academic career, she practiced community pharmacy for over 14 years and has provided assistance on various legal cases regarding pharmacy law issues.



 

Randy Hatton, PharmD

Randy Hatton, PharmD

Randy Hatton, Pharm.D., is the academic director of the second year of the College of Pharmacy’s curriculum. he teaches the evidence-based pharmacy course and content throughout the first 3 years of pharmacy education. He also serves as a clinical pharmacist in Internal Medicine Service at UF Health Shands Hospital, providing clinical pharmacy services while supervising working-professional doctor of pharmacy students.

 
 
 
 

Karen Rascati

Karen Rascati

Dr. Karen Rascati’s research interests include economic and outcomes evaluations for several disease states as well as for pharmacy services. She has conducted over 60 funded research projects and has served on various grant review panels. She has supervised 40 MS and 25 PhD graduate student projects. She has authored or co-authored more than 100 publications (including five textbook chapters) and more than 100 national and international presentations. Her textbook, Essentials of Pharmacoeconomics was published in 2008, and was translated into Portuguese in 2009. In addition, she received the 2009 University of Texas Hamilton Book Award. The second edition became available in 2013.

 

Kraig L. Schell, Ph.D.

Kraig L. Schell, Ph.D.

Kraig L. Schell is Professor of Psychology, Director of the Consultation and Research Institute (CRI), and Director of Academic Assessment at Angelo State University (TX) as well as Affiliate Professor of Pharmaceutical Outcomes and Policy at the University of Florida. Dr. Schell’s pharmacy-relevant expertise is in the application of psychological principles to patient safety, patient engagement, and employee well-being, as well as organizational assessment and evaluation of processes. He has served as an expert witness in patient safety and has written continuing education for several outlets, including McKesson’s PharmSafety.org, Texas Tech’s Health.edu and RxLaw.

 

 



Gary L. Yingling

Gary L. Yingling

Gary L. Yingling draws on his experience as a former US Food and Drug Administration (FDA) lawyer to advise individuals, partnerships, and corporations in matters involving new drug applications, food ingredient marketing, product labeling, importation, regulatory marketing strategy, recalls, seizures, and criminal matters. His practice focuses on food and drug industry issues, with a particular interest in clinical research, contract research organization, and sponsor matters. Clients seek his advice in matters ranging from ingredient safety questions and product labeling to the preparation of New Drug Applications (NDA) and GRAS Notifications.


At a Glance